Transport Studies Using Blood-Brain Barrier In Vitro Models: A Critical Review and Guidelines
- 11 October 2020
- book chapter
- Published by Springer Nature
- p. 187-204
Abstract
Permeation is one of the most evaluated parameters using preclinical in vitro blood-brain barrier models, as it has long been considered to be one of the major factors influencing central nervous system drug delivery. Blood-brain barrier permeability can be defined as the speed at which a compound crosses the brain endothelial cell barrier and is employed to assess barrier tightness, which is a crucial feature of brain capillaries in vivo. In addition, it is used to assess brain drug penetration. We review traditionally used methods to assess blood-brain barrier permeability in vitro and summarize often neglected in vivo (e.g., plasma protein and brain tissue binding) or in vitro (e.g., culture insert materials or methodology) factors that influence this property. These factors are crucial to consider when performing BBB permeability assessments, and especially when comparing permeability data obtained from different models, since model diversification significantly complicates inter-study comparisons. Finally, measuring transendothelial electrical resistance can be used to describe blood-brain barrier tightness; however, several parameters should be considered while comparing these measurements to the blood-brain barrier permeability to paracellular markers.Keywords
This publication has 51 references indexed in Scilit:
- Dual Action of the PN159/KLAL/MAP Peptide: Increase of Drug Penetration across Caco-2 Intestinal Barrier Model by Modulation of Tight Junctions and Plasma Membrane PermeabilityPharmaceutics, 2019
- Establishment of a Human Blood-Brain Barrier Co-culture Model Mimicking the Neurovascular Unit Using Induced Pluri- and Multipotent Stem CellsStem Cell Reports, 2017
- Stem Cell-Based Human Blood–Brain Barrier Models for Drug Discovery and DeliveryTrends in Biotechnology, 2016
- Pitfalls in assessing microvascular endothelial barrier function: impedance-based devices versus the classic macromolecular tracer assayScientific Reports, 2016
- From blood–brain barrier to blood–brain interface: new opportunities for CNS drug deliveryNature Reviews Drug Discovery, 2016
- In Vitro Assays for Assessing BBB Permeability2015
- “You Shall Not Passâ€â€”tight junctions of the blood brain barrierFrontiers in Neuroscience, 2014
- In Vitro Models of CNS Barriers2013
- Impedance-based cell monitoring: barrier properties and beyondFluids and Barriers of the CNS, 2013
- Structure and function of the blood–brain barrierNeurobiology of Disease, 2010